Author

Mattias Mandorfer

LATE-STAGE PRESENTATION OF CIRRHOSIS WITH DECOMPENSATION IS ALARMINGLY COMMON AND FAVORABLE OUTCOME IS ONLY OBSERVED WITH ETIOLOGIC THERAPY
LATE-STAGE PRESENTATION OF CIRRHOSIS WITH DECOMPENSATION IS ALARMINGLY COMMON AND FAVORABLE OUTCOME IS ONLY OBSERVED WITH ETIOLOGIC THERAPY

Mattias Mandorfer  et al.

A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS

Mattias Mandorfer  et al.

ENDOSCOPIC VARICEAL BAND LIGATION IS SAFE DESPITE LOW PLATELET COUNT AND HIGH INR
ENDOSCOPIC VARICEAL BAND LIGATION IS SAFE DESPITE LOW PLATELET COUNT AND HIGH INR

Mattias Mandorfer  et al.

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

Mattias Mandorfer  et al.

DISTURBANCES IN SODIUM AND CHLORIDE HOMEOSTASIS PREDICT OUTCOMES IN STABLE AND CRITICALLY ILL PATIENTS WITH CIRRHOSIS – NOT TWO SIDES OF THE SAME COIN
DISTURBANCES IN SODIUM AND CHLORIDE HOMEOSTASIS PREDICT OUTCOMES IN STABLE AND CRITICALLY ILL PATIENTS WITH CIRRHOSIS – NOT TWO SIDES OF THE SAME COIN

Mattias Mandorfer  et al.

DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)
DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)

Mattias Mandorfer  et al.

ACUTE HAEMODYNAMIC RESPONSE TO INTRAVENOUS PROPRANOLOL PREDICTS DECOMPENSATION AND MORTALITY IN PATIENTS WITH CIRRHOSIS
ACUTE HAEMODYNAMIC RESPONSE TO INTRAVENOUS PROPRANOLOL PREDICTS DECOMPENSATION AND MORTALITY IN PATIENTS WITH CIRRHOSIS

Mattias Mandorfer  et al.

HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS
HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS

Mattias Mandorfer  et al.

THE IMPACT OF PNPLA3 RS738409 RISK G ALLELES ON HEPATIC STEATOSIS, THE METABOLIC SYNDROME AND PORTAL HYPERTENSION IN ADVANCED FATTY LIVER DISEASE
THE IMPACT OF PNPLA3 RS738409 RISK G ALLELES ON HEPATIC STEATOSIS, THE METABOLIC SYNDROME AND PORTAL HYPERTENSION IN ADVANCED FATTY LIVER DISEASE

Mattias Mandorfer  et al.

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

Mattias Mandorfer  et al.

PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER
PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER

Mattias Mandorfer  et al.

ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS
ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS

Mattias Mandorfer  et al.

CARVEDILOL INDUCES HIGHER HVPG RESPONSE RATES AND IS ASSOCIATED WITH LOWER RATES OF VARICEAL REBLEEDING THAN PROPRANOLOL IN SECONDARY PROPHYLAXIS OF PORTAL HYPERTENSION - A RETROSPECTIVE COHORT STUDY
CARVEDILOL INDUCES HIGHER HVPG RESPONSE RATES AND IS ASSOCIATED WITH LOWER RATES OF VARICEAL REBLEEDING THAN PROPRANOLOL IN SECONDARY PROPHYLAXIS OF PORTAL HYPERTENSION - A RETROSPECTIVE COHORT STUDY

Mattias Mandorfer  et al.

SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION

Mattias Mandorfer  et al.

VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE
VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE

Mattias Mandorfer  et al.

CLINICAL COURSE OF FURTHER DECOMPENSATION/MORTALITY IN PATIENTS WITH CIRRHOSIS AND ASCITES AS THE FIRST SINGLE DECOMPENSATION EVENT – AN INCEPTION COHORT STUDY
CLINICAL COURSE OF FURTHER DECOMPENSATION/MORTALITY IN PATIENTS WITH CIRRHOSIS AND ASCITES AS THE FIRST SINGLE DECOMPENSATION EVENT – AN INCEPTION COHORT STUDY

Mattias Mandorfer  et al.

THE IMPACT OF TRANSMEMBRANE 6 SUPERFAMILY 2 (TM6SF2) RS58542926 ON LIVER-RELATED EVENTS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
THE IMPACT OF TRANSMEMBRANE 6 SUPERFAMILY 2 (TM6SF2) RS58542926 ON LIVER-RELATED EVENTS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Mattias Mandorfer  et al.

THE ALPHA-1 ANTITRYPSIN PI*Z ALLELE INDEPENDENTLY PREDICTS LIVER TRANSPLANTATION/DEATH IN ACLD PATIENTS
THE ALPHA-1 ANTITRYPSIN PI*Z ALLELE INDEPENDENTLY PREDICTS LIVER TRANSPLANTATION/DEATH IN ACLD PATIENTS

Mattias Mandorfer  et al.

FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Mattias Mandorfer  et al.

CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Mattias Mandorfer  et al.

Item 1 - 20 / 21
1
2